Matthew Hamilton Rosenberg’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77K | Buy |
173
+21
| +14% | +$9.35K | 0.02% | 382 |
|
|
2025
Q1 | $73.7K | Hold |
152
| – | – | 0.02% | 361 |
|
|
2024
Q4 | $61.2K | Hold |
152
| – | – | 0.02% | 389 |
|
|
2024
Q3 | $70.7K | Hold |
152
| – | – | 0.02% | 372 |
|
|
2024
Q2 | $71.6K | Hold |
152
| – | – | 0.02% | 362 |
|
|
2024
Q1 | $63.9K | Hold |
152
| – | – | 0.02% | 390 |
|
|
2023
Q4 | $61.8K | Hold |
152
| – | – | 0.02% | 393 |
|
|
2023
Q3 | $52.9K | Hold |
152
| – | – | 0.02% | 407 |
|
|
2023
Q2 | $53.5K | Buy |
152
+1
| +0.7% | +$352 | 0.02% | 418 |
|
|
2023
Q1 | $47.6K | Hold |
151
| – | – | 0.02% | 473 |
|
|
2022
Q4 | $43.6K | Hold |
151
| – | – | 0.01% | 494 |
|
|
2022
Q3 | $44K | Buy |
151
+16
| +12% | +$4.66K | 0.02% | 473 |
|
|
2022
Q2 | $39K | Hold |
135
| – | – | 0.01% | 515 |
|
|
2022
Q1 | $35K | Hold |
135
| – | – | 0.01% | 500 |
|
|
2021
Q4 | $30K | Hold |
135
| – | – | 0.01% | 488 |
|
|
2021
Q3 | $24K | Hold |
135
| – | – | 0.01% | 491 |
|
|
2021
Q2 | $27K | Hold |
135
| – | – | 0.01% | 444 |
|
|
2021
Q1 | $29K | Hold |
135
| – | – | 0.02% | 402 |
|
|
2020
Q4 | $32K | Hold |
135
| – | – | 0.02% | 377 |
|
|
2020
Q3 | $37K | Hold |
135
| – | – | 0.03% | 336 |
|
|
2020
Q2 | $39K | Hold |
135
| – | – | 0.03% | 335 |
|
|
2020
Q1 | $33K | Buy |
+135
| New | +$33K | 0.03% | 317 |
|